Plain-English translation of NCT06712628 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study compares how well two different arthritis treatments work over time in real-world conditions in Germany. Researchers will follow people with moderate to severe rheumatoid arthritis who are taking either upadacitinib or a TNF inhibitor medication (another common arthritis drug) to see how long patients stay on each treatment and whether they switch or stop taking it.
Both medications are used to treat rheumatoid arthritis, but doctors want to understand which one people actually stick with long-term and whether one is better at keeping patients on treatment in everyday practice.
You likely qualify if…
You likely don't qualify if…
You will take your arthritis medication as your doctor prescribes it—the study is not asking you to do anything different from your normal care. Researchers will track your medical records for up to 24 months to see whether you continue taking the medication, switch to something else, or stop treatment. The study itself will run for about 4 years total across approximately 80 medical centers in Germany.
AI-generated summary from trial data · Aug 12, 2026 · Not medical advice
Germany